+ Watch AFFY
on My Watchlist
The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.
Wish I would't have sold 30% of my shares. Hope to see $12 in a month
Uh, now I am guessing you wish you had sold all of it !I had this stock for awhle about a year ago and only made about 5% on it and decided it was not worth the risk of failure with their only product. I think people need to consider these consequences. At this new price, I might be willing to risk a few bucks on a comeback if it levels out in price after a week, but realizing it could go bankrupt. In my estimatation, this stock is not even worth $1.80 without the drug.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions